American Society of Hirudotherapy

Exploring the use of the medicinal leech: a clinical risk-benefit analysis

Risk-benefit analysis published in Journal of Reconstructive Microsurgery (1996)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportClinical TrialsSafety & Infection Controlde Chalain TM · Journal of reconstructive microsurgery, 1996

Abstract

The medicinal leech, Hirudo medicinalis, has been used with increasing frequency for salvage of compromised pedicled flaps and microvascular free-tissue transfers. The data pertaining to 18 cases in which flap salvage with leeches was attempted were reviewed and contrasted with the data from 108 published cases from other centers. A further analysis isolated and examined 19 cases in which infection, secondary to leech utilization, supervened. Results suggested that successful salvage of tissue with leeches occurs in 70 to 80 percent of cases. In contrast, the infection rate of most series is between 7 and 20 percent and, when a clinically significant infection occurs, the flap salvage rate drops to 30 percent or less. In addition to infection, the risks of leech therapy include blood loss, which may require replacement transfusion, loss of leeches into body orifices and spaces, allergic reactions, and adverse psychological responses. Clinical indications and contraindications, and strategies to reduce the risks of leech usage, are discussed. Conclusions are that leeches are best used early, and in accordance with an accepted institutional protocol. For each case, the potential risks and benefits must be rigorously assessed and honestly applied.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAdultAeromonas hydrophilaAnimalsBlood TransfusionCase-Control StudiesFemaleGram-Negative Bacterial InfectionsHumansIncidenceLeechesMalePostoperative Complications

Summary

Authoritative clinical risk-benefit analysis of medicinal leech therapy covering anticoagulant effect, blood loss, infection risk, allergic and ethical considerations.

Why This Matters for Hirudotherapy

This article reviews 18 clinical cases and 108 published cases of medicinal leech (Hirudo medicinalis) use for salvaging compromised pedicled flaps and microvascular free-tissue transfers. It is highly relevant to the American Society of Hirudotherapy, providing concrete clinical data on the risk-benefit profile of leech therapy, noting a 70 to 80 percent tissue salvage success rate alongside a 7 to 20 percent infection rate that drastically reduces salvage success. While comprehensive, the analysis aggregates historical cases without a standardized, prospective control group. The abstract emphasizes that leech usage carries distinct risks—including blood loss requiring transfusion, allergic reactions, and psychological impacts—necessitating rigorous protocol-based assessment rather than casual application.

Citation

Exploring the use of the medicinal leech: a clinical risk-benefit analysis.

de Chalain TM · Journal of reconstructive microsurgery, 1996

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.